Latest news
Did Expanding Ivonescimab Into First-Line Bladder Cancer Just Shift Summit Therapeutics' (SMMT) Investment Narrative? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 22:09:14 GMTBiotech Stocks: The New Drugs That Could Fuel Big Gains - Barron'sBarron's · Fri, 07 Aug 2026 05:15:00 GMTWhy Is SMMT Stock Tumbling Today? - StocktwitsStocktwits · Fri, 07 Aug 2026 03:14:53 GMTLowey Dannenberg, P.C. is Investigating Summit Therapeutics - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:07:03 GMTSummit Therapeutics Inc. (SMMT) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Thu, 06 Aug 2026 13:50:50 GMTH.C. Wainwright Reiterates Neutral Rating on Summit Therapeutics plc (SMMT) - StreetInsiderStreetInsider · Thu, 06 Aug 2026 10:56:23 GMTSummit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab - YahooYahoo · Thu, 06 Aug 2026 10:46:44 GMTSummit expands ivonescimab's challenge to Keytruda into bladder cancer - AllSciAllSci · Thu, 06 Aug 2026 09:59:29 GMT